Aeterna Zentaris Hits $1 Mark: A Bullish Sign?

The coronavirus pandemic has created a unique opportunity for investors to get into stocks that are working on vaccines to tackle the spread of the virus. Many companies have sprung up as potential options in recent times and the latest on the block is Aeterna Zentaris Inc. (NASDAQ: AEZS).

Pharma Banner

The Aeterna stock came into focus yesterday after the company announced that it signed an exclusive options agreement with regards to a COVID-19 vaccine that is being currently developed at the Julius-Maximilians-University Wuerzburg.

The announcement proved to be a major boost for the Aeterna stock and it rallied by as much as 43% as investors piled on to it in considerable numbers. As per the provisions of the agreement, the company is also going to have the right to have an exclusive worldwide license to develop the technology. However, it should be noted that Aeterna would need to negotiate a price for the same. Considering the latest development, it might be a good idea for investors to keep an eye on the stock this week.

Focus Health Insurance main

Alex Krakowsky

Editor in Chief. Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life

Alex Krakowsky has 978 posts and counting. See all posts by Alex Krakowsky